These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 33177491

  • 21. Fucoxanthin extracted from Laminaria Japonica inhibits metastasis and enhances the sensitivity of lung cancer to Gefitinib.
    Ming JX, Wang ZC, Huang Y, Ohishi H, Wu RJ, Shao Y, Wang H, Qin MY, Wu ZL, Li YY, Chang Zhou S, Chen H, Liu H, Xu R.
    J Ethnopharmacol; 2021 Jan 30; 265():113302. PubMed ID: 32860893
    [Abstract] [Full Text] [Related]

  • 22. FBP1 induced by β-elemene enhances the sensitivity of gefitinib in lung cancer.
    Li J, Dai P, Sun J, Yu W, Han W, Li K.
    Thorac Cancer; 2023 Feb 30; 14(4):371-380. PubMed ID: 36525508
    [Abstract] [Full Text] [Related]

  • 23. Autophagy Inhibition Overcomes the Antagonistic Effect Between Gefitinib and Cisplatin in Epidermal Growth Factor Receptor Mutant Non--Small-Cell Lung Cancer Cells.
    Liu JT, Li WC, Gao S, Wang F, Li XQ, Yu HQ, Fan LL, Wei W, Wang H, Sun GP.
    Clin Lung Cancer; 2015 Sep 30; 16(5):e55-66. PubMed ID: 25979647
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3.
    Yue J, Lv D, Wang C, Li L, Zhao Q, Chen H, Xu L.
    Oncogene; 2018 Aug 30; 37(31):4300-4312. PubMed ID: 29717264
    [Abstract] [Full Text] [Related]

  • 26. Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3.
    Shou J, You L, Yao J, Xie J, Jing J, Jing Z, Jiang L, Sui X, Pan H, Han W.
    Cancer Lett; 2016 Aug 28; 379(1):124-33. PubMed ID: 27264264
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Combined Treatment with JFKD and Gefitinib Overcomes Drug Resistance in Non-Small Cell Lung Cancer.
    Huang X, Sun J, Sun J.
    Curr Pharm Biotechnol; 2021 Aug 28; 22(3):389-399. PubMed ID: 32819223
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. 20(R)-Panaxatriol enhances METTL3-mediated m6A modification of STUB1 to inhibit autophagy and exert antitumor effects in Triple-Negative Breast Cancer cells.
    Li Y, Luo B, Lin X, Bai D, Li L, Gao D, Li X, Zhong X, Wei Y, Yang L, Zhu X, Han L, Tian H, Zhang R, Wang P.
    Phytomedicine; 2024 Jul 25; 130():155537. PubMed ID: 38823344
    [Abstract] [Full Text] [Related]

  • 32. Targeting METTL3 enhances the chemosensitivity of non-small cell lung cancer cells by decreasing ABCC2 expression in an m6A-YTHDF1-dependent manner.
    Zhang R, Chen P, Wang Y, Zeng Z, Yang H, Li M, Liu X, Yu W, Hou P.
    Int J Biol Sci; 2024 Jul 25; 20(12):4750-4766. PubMed ID: 39309428
    [Abstract] [Full Text] [Related]

  • 33. The combination of methionine adenosyltransferase 2A inhibitor and methyltransferase like 3 inhibitor promotes apoptosis of non-small cell lung cancer cells and produces synergistic anti-tumor activity.
    Xuan YF, Lu S, Ou YJ, Bao XB, Huan XJ, Song SS, Miao ZH, Wang YQ.
    Biochem Biophys Res Commun; 2024 Jul 05; 716():150011. PubMed ID: 38704890
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Baicalin induces cell death of non-small cell lung cancer cells via MCOLN3-mediated lysosomal dysfunction and autophagy blockage.
    Dong X, Liu X, Lin D, Zhang L, Wu Y, Chang Y, Jin M, Huang G.
    Phytomedicine; 2024 Oct 05; 133():155872. PubMed ID: 39096542
    [Abstract] [Full Text] [Related]

  • 36. The canonical TGF-β/Smad signalling pathway is involved in PD-L1-induced primary resistance to EGFR-TKIs in EGFR-mutant non-small-cell lung cancer.
    Zhang Y, Zeng Y, Liu T, Du W, Zhu J, Liu Z, Huang JA.
    Respir Res; 2019 Jul 22; 20(1):164. PubMed ID: 31331328
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells.
    Hwang KE, Kim YS, Jung JW, Kwon SJ, Park DS, Cha BK, Oh SH, Yoon KH, Jeong ET, Kim HR.
    Oncotarget; 2015 Oct 06; 6(30):29482-96. PubMed ID: 26334320
    [Abstract] [Full Text] [Related]

  • 38. Apatinib enhances antitumour activity of EGFR-TKIs in non-small cell lung cancer with EGFR-TKI resistance.
    Li F, Zhu T, Cao B, Wang J, Liang L.
    Eur J Cancer; 2017 Oct 06; 84():184-192. PubMed ID: 28822888
    [Abstract] [Full Text] [Related]

  • 39. ID1 overexpression increases gefitinib sensitivity in non-small cell lung cancer by activating RIP3/MLKL-dependent necroptosis.
    Tan HY, Wang N, Chan YT, Zhang C, Guo W, Chen F, Zhong Z, Li S, Feng Y.
    Cancer Lett; 2020 Apr 10; 475():109-118. PubMed ID: 32004572
    [Abstract] [Full Text] [Related]

  • 40. TAZ sensitizes EGFR wild-type non-small-cell lung cancer to gefitinib by promoting amphiregulin transcription.
    Yuan W, Xu W, Li Y, Jiang W, Li Y, Huang Q, Chen B, Wu S, Wang Y, Song W, Zhao W, Wu J.
    Cell Death Dis; 2019 Mar 25; 10(4):283. PubMed ID: 30911072
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.